首页 | 本学科首页   官方微博 | 高级检索  
检索        


Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages
Authors:Kravitz Richard L  Duan Naihua  Braslow Joel
Institution:University of California, Davis, CA, USA. rlkravitz@ucdavis.edu
Abstract:Evidence-based medicine is the application of scientific evidence to clinical practice. This article discusses the difficulties of applying global evidence ("average effects" measured as population means) to local problems (individual patients or groups who might depart from the population average). It argues that the benefit or harm of most treatments in clinical trials can be misleading and fail to reveal the potentially complex mixture of substantial benefits for some, little benefit for many, and harm for a few. Heterogeneity of treatment effects reflects patient diversity in risk of disease, responsiveness to treatment, vulnerability to adverse effects, and utility for different outcomes. Recognizing these factors, researchers can design studies that better characterize who will benefit from medical treatments, and clinicians and policymakers can make better use of the results.
Keywords:Evidence-based medicine  research design  population characteristics  genomics  statistics  United States Food and Drug Administration
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号